{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:12:36Z","timestamp":1762542756178,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502275"],"award-info":[{"award-number":["81502275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12957-017-1252-y","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T07:59:37Z","timestamp":1508140777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs"],"prefix":"10.1186","volume":"15","author":[{"given":"Qi","family":"Gui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1148\/radiol.2423051707","volume":"242","author":"A Mujoomdar","year":"2007","unstructured":"Mujoomdar A, Austin JH, Malhotra R, et al. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology. 2007;242:882\u20138.","journal-title":"Radiology"},{"key":"1252_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-5002(03)00291-5","volume":"42","author":"MM Hochstenbag","year":"2003","unstructured":"Hochstenbag MM, Twijnstra A, Hofman P, Wouters EF, ten Velde GP. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003;42:189\u201393.","journal-title":"Lung Cancer"},{"key":"1252_CR3","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U","volume":"78","author":"ES Nussbaum","year":"1996","unstructured":"Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996;78:1781\u20138.","journal-title":"Cancer"},{"key":"1252_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, Heeroma K, Itoh Y, Cornelio G, Yang PC. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol. 2014;9:154\u201362.","journal-title":"J Thorac Oncol"},{"key":"1252_CR5","doi-asserted-by":"crossref","first-page":"56998","DOI":"10.18632\/oncotarget.10933","volume":"35","author":"G Han","year":"2016","unstructured":"Han G, Bi J, Tan W, Wei X, Wang X, Ying X, Guo X, Zhou X, Hu D, Zhen W. A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis? Oncotarget. 2016;35:56998\u20137010.","journal-title":"Oncotarget"},{"key":"1252_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2478\/raon-2014-0016","volume":"48","author":"K Stanic","year":"2014","unstructured":"Stanic K, Zwitter M, Hitij NT, Kern I, Sadikov A, Cufer T. Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival. Radiol Oncol. 2014;48:173\u201383.","journal-title":"Radiol Oncol"},{"key":"1252_CR7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cncr.22399","volume":"109","author":"L Moscetti","year":"2007","unstructured":"Moscetti L, Nelli F, Felici A, Rinaldi M, De Santis S, D\u2019Auria G, et al. Up-front chemotherapy and radiation treatment in newly diagnosed treatment nonsmall cell lung cancer with brain metastases: survey by outcome research network for evaluation of treatment results in oncology. Cancer. 2007;109:274\u201381.","journal-title":"Cancer"},{"key":"1252_CR8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.lungcan.2012.05.092","volume":"77","author":"SJ Park","year":"2012","unstructured":"Park SJ, Kim HT, Lee DH, Kim KP, Kim SW, Suh C, Le JS. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastases in non-small-cell lung cancer harbouring either exon 19 or 21 mutation. Lung Cancer. 2012;77:556\u201360.","journal-title":"Lung Cancer"},{"key":"1252_CR9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1200\/JCO.2011.40.1174","volume":"31","author":"JW Welsh","year":"2013","unstructured":"Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, et al. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol. 2013;31:895\u2013902.","journal-title":"J Clin Oncol"},{"key":"1252_CR10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/neuonc\/nos328","volume":"15","author":"EP Connolly","year":"2013","unstructured":"Connolly EP, Mathew M, Tam M, King JV, Kunnakkat SD, Parker EC, Golfinos JG, Gruber ML, Narayana A. Involved field radiation therapy after surgical resection of solitary brain metastases\u2014mature results. Neuro-Oncology. 2013;15:589\u201394.","journal-title":"Neuro-Oncology"},{"key":"1252_CR11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494\u2013500.","journal-title":"N Engl J Med"},{"key":"1252_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-8-64","volume":"8","author":"S Ohara","year":"2014","unstructured":"Ohara S, Ushijima T, Gunji M, Tanai C, Tanaka Y, Noda H, et al. Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report. J Med Case Rep. 2014;8:1\u20135.","journal-title":"J Med Case Rep"},{"key":"1252_CR13","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1378\/chest.119.5.1469","volume":"119","author":"P Bonnette","year":"2001","unstructured":"Bonnette P, Puyo P, Gabriel C, et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest. 2001;119:1469\u201375.","journal-title":"Chest"},{"key":"1252_CR14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/cncr.25416","volume":"117","author":"JS Lind","year":"2011","unstructured":"Lind JS, Lagerwaard FJ, Smit EF, et al. Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancer. Cancer. 2011;117:597\u2013605.","journal-title":"Cancer"},{"key":"1252_CR15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cllc.2012.06.004","volume":"14","author":"J Zhao","year":"2013","unstructured":"Zhao J, Chen M, Zhong W, Zhang L, Li L, Xiao Y, Nie L, Hu P, Wang M. Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma. Clin Lung Cancer. 2013;14:188\u201393.","journal-title":"Clin Lung Cancer"},{"key":"1252_CR16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ijrobp.2012.09.025","volume":"85","author":"J Ebi","year":"2013","unstructured":"Ebi J, Sato H, Nakajima M, Shishido F. Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases. Int J Radiat Oncol Biol Phys. 2013;85:1212\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1252_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"R Soffietti","year":"2013","unstructured":"Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, et al. A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumours after surgical resection or radio- surgery: quality-of-life results. J Clin Oncol. 2013;31:65\u201372.","journal-title":"J Clin Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-017-1252-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T07:59:42Z","timestamp":1508140782000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-017-1252-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1186\/s12957-017-1252-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2017,10,16]]},"article-number":"184"}}